National Institute on Drug Abuse

Sonara Health CEO Michael Giles, M.D. [Images: LinkedIn/Sonara Health]

Sonara Health Gets $2.5M NIDA Grant to Advance Remote Methadone Treatment

by Lance Murray | Oct 22, 2024

The $2.5 million Small Business Innovation Research (SBIR) grant awarded by the National Institute on Drug Abuse will fund the second phase of Sonara's Remote Observed Methadone Evaluation study, the company said.

MORE►

UTSW Leads 3 Studies That Are Largest Ever for Stimulant Use Disorders

by Lance Murray | Dec 30, 2023

Researchers at Dallas’ UT Southwestern Medical Center are leading three multicenter clinical trials focused on potential treatment for methamphetamine or cocaine addiction that are funded by the National Institute on Drug Abuse (NIDA)....

MORE►

Follow the Money: Medical Device Firm Orthofix Merges to Form Nearly $700M Revenue Business, Stealthy Men’s Health Startup Looks to Raise $2M, Dallas SPAC Targets $200M IPO, and More

by Kevin Cummings | Oct 17, 2022

In this week’s North Texas deal flow, you’ll also find news about Mavenir’s $155M raise, Pinnacle Realty Advisors raising $5M for ‘brokerage-as-a-service’ platform, Exela Technologies taking its European business unit public, American Airlines’ hydrogen fuel distribution investment, and more.

MORE►